Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Colorcon
Boehringer Ingelheim
Baxter
Merck

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)

See Plans and Pricing

« Back to Dashboard

Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)

Docket   Start Trial Date Filed 2017-07-28
Court District Court, E.D. Texas Date Terminated 2018-06-22
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Plaintiff Referred To
Parties ENDO PHARMACEUTICALS INC.; HARRY LEE GILLAM; LUPIN ATLANTIS HOLDINGS SA
Patents 7,229,636; 7,404,489; 7,879,349; 8,003,353; 8,940,714; 9,415,007
Attorneys Jennifer Koh; Kurt A Mathas; Michael Brett Johnson; Michael Keenan Nutter; Sarah Wenxuan Wang; William Ellsworth Davis , III
Firms Latham & Watkins - Chicago; Latham & Watkins LLP - San Diego; The Davis Firm, PC Longview; Winston & Strawn LLP - Chicago; Winston & Strawn LLP - Dallas
Link to Docket External link to docket
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 U.S. Patent No. 7,229,636, # 2 Exhibit B - U.S. Patent No. 7,404,489, # 3 Exhibit C - U.S. Patent No. …U.S. Patent No. 8,003,353, # 5 Exhibit E - U.S. Patent No. 8,940,714, # 6 Exhibit F - U.S. Patent No. … COMPLAINT for Patent Infringement against Lupin Atlantis Holdings SA ( Filing fee $ 400 receipt…2017 22 June 2018 2:17-cv-00558 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Boehringer Ingelheim
Mallinckrodt
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.